T1	B-Protein	0	4	CD30	CD30	B-NP	NN	B-protein	2	SUB	B-protein
O	O	5	7	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	8	9	a	a	B-NP	DT	O	7	NMOD	O
T2	B-Protein	10	14	CD40	CD40	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	14	15	-	-	B-NP	HYPH	O	7	NMOD	O
O	O	15	24	inducible	inducible	I-NP	JJ	O	7	NMOD	O
O	O	25	33	molecule	molecule	I-NP	NN	O	2	PRD	O
O	O	34	38	that	that	B-NP	WDT	O	7	NMOD	O
O	O	39	49	negatively	negatively	B-ADVP	RB	O	10	VMOD	O
O	O	50	59	regulates	regulate	B-VP	VBZ	O	8	SBAR	O
T3	B-Protein	60	64	CD40	CD40	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	64	65	-	-	O	HYPH	O	11	P	O
O	O	65	73	mediated	mediate	B-NP	VBN	O	11	AMOD	O
O	O	74	88	immunoglobulin	immunoglobulin	I-NP	NN	O	16	NMOD	O
O	O	89	94	class	class	I-NP	NN	O	16	NMOD	O
O	O	95	104	switching	switching	I-NP	NN	O	10	OBJ	O
O	O	105	107	in	in	B-PP	IN	O	10	VMOD	O
O	O	108	111	non	non	B-NP	AFX	O	25	NMOD	O
O	O	111	112	-	-	I-NP	HYPH	B-protein	25	NMOD	B-protein
O	O	112	119	antigen	antigen	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	119	120	-	-	B-VP	HYPH	O	25	P	O
O	O	120	128	selected	select	B-NP	VBN	O	25	NMOD	O
O	O	129	134	human	human	I-NP	JJ	B-cell_type	25	NMOD	B-cell_type
O	O	135	136	B	B	I-NP	NN	I-cell_type	25	NMOD	I-cell_type
O	O	137	142	cells	cell	I-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	142	143	.	.	O	.	O	2	P	O

O	O	145	147	We	We	B-NP	PRP	O	2	SUB	O
O	O	148	152	used	use	B-VP	VBD	O	0	ROOT	O
O	O	153	156	our	our	B-NP	PRP$	O	5	NMOD	O
O	O	157	167	monoclonal	monoclonal	I-NP	JJ	O	5	NMOD	O
O	O	168	173	model	model	I-NP	NN	O	2	OBJ	O
O	O	174	176	of	of	B-PP	IN	O	5	NMOD	O
O	O	177	185	germinal	germinal	B-NP	JJ	O	9	NMOD	O
O	O	186	192	center	center	I-NP	NN	O	9	NMOD	O
O	O	193	203	maturation	maturation	I-NP	NN	O	15	NMOD	O
O	O	203	204	,	,	O	,	O	15	P	O
O	O	205	207	CL	CL	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	207	208	-	-	B-NP	HYPH	I-cell_line	15	P	I-cell_line
O	O	208	210	01	01	I-NP	CD	I-cell_line	15	NMOD	I-cell_line
O	O	211	212	B	B	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	213	218	cells	cell	I-NP	NNS	I-cell_line	6	PMOD	I-cell_line
O	O	218	219	,	,	O	,	O	2	P	O
O	O	220	222	to	to	B-VP	TO	O	18	VMOD	O
O	O	223	234	investigate	investigate	I-VP	VB	O	2	VMOD	O
O	O	235	238	the	the	B-NP	DT	O	20	NMOD	O
O	O	239	243	role	role	I-NP	NN	O	18	OBJ	O
O	O	244	246	of	of	B-PP	IN	O	20	NMOD	O
T4	B-Protein	247	251	CD30	CD30	B-NP	NN	B-protein	21	PMOD	B-protein
O	O	252	254	in	in	B-PP	IN	O	20	NMOD	O
O	O	255	260	human	human	B-NP	JJ	B-cell_type	27	NMOD	B-cell_type
O	O	261	262	B	B	I-NP	NN	I-cell_type	27	NMOD	I-cell_type
O	O	263	267	cell	cell	I-NP	NN	I-cell_type	27	NMOD	I-cell_type
O	O	268	283	differentiation	differentiation	I-NP	NN	O	23	PMOD	O
O	O	283	284	.	.	O	.	O	2	P	O

O	O	285	287	CL	CL	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	287	288	-	-	I-NP	HYPH	I-cell_line	4	NMOD	I-cell_line
O	O	288	290	01	01	I-NP	CD	I-cell_line	4	NMOD	I-cell_line
O	O	291	296	cells	cell	I-NP	NNS	I-cell_line	5	SUB	I-cell_line
O	O	297	300	are	be	B-VP	VBP	O	0	ROOT	O
O	O	301	304	IgM	IgM	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	304	305	+	+	B-NP	SYM	O	10	NMOD	O
O	O	306	309	IgD	IgD	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	309	310	+	+	I-NP	SYM	O	10	NMOD	O
T5	B-Protein	311	315	CD30	CD30	I-NP	NN	B-protein	5	PRD	B-protein
O	O	315	316	+	+	B-NP	SYM	O	10	NMOD	O
O	O	317	320	and	and	O	CC	O	11	VMOD	O
O	O	321	327	switch	switch	B-VP	VB	O	11	AMOD	O
O	O	328	330	to	to	B-PP	TO	O	13	VMOD	O
O	O	331	334	IgG	IgG	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	334	335	,	,	O	,	O	20	P	O
O	O	336	339	IgA	IgA	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	339	340	,	,	O	,	O	20	P	O
O	O	341	344	and	and	O	CC	O	20	NMOD	O
O	O	345	348	IgE	IgE	B-NP	NN	B-protein	14	PMOD	B-protein
O	O	349	353	when	when	B-ADVP	WRB	O	13	VMOD	O
O	O	354	361	exposed	expose	B-VP	VBN	O	21	SBAR	O
O	O	362	364	to	to	B-PP	TO	O	22	VMOD	O
T6	B-Protein	365	370	CD40L	CD40L	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	371	374	and	and	I-NP	CC	O	28	NMOD	O
T7	B-Protein	375	377	IL	IL	I-NP	NN	B-protein	28	NMOD	B-protein
T7	I-Protein	377	378	-	-	O	:	I-protein	28	P	I-protein
T7	I-Protein	378	379	4	4	B-NP	CD	I-protein	23	PMOD	I-protein
O	O	379	380	.	.	O	.	O	5	P	O

O	O	381	390	Switching	Switching	B-NP	NN	O	2	SUB	O
O	O	391	393	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	394	402	hampered	hamper	I-VP	VBN	O	2	VC	O
O	O	403	405	by	by	B-PP	IN	O	3	VMOD	O
T8	B-Protein	406	410	CD30	CD30	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	411	423	coengagement	coengagement	I-NP	NN	O	4	PMOD	O
O	O	423	424	,	,	O	,	O	3	P	O
O	O	425	433	possibly	possibly	B-ADVP	RB	O	9	PMOD	O
O	O	434	441	through	through	B-PP	IN	O	3	VMOD	O
O	O	442	454	interference	interference	B-NP	NN	O	9	PMOD	O
O	O	455	459	with	with	B-PP	IN	O	10	NMOD	O
O	O	460	463	the	the	B-NP	DT	O	22	NMOD	O
T9	B-Protein	464	468	CD40	CD40	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	468	469	-	-	B-VP	HYPH	O	22	P	O
O	O	469	477	mediated	mediate	B-NP	VBN	O	22	NMOD	O
T16	B-Entity	478	480	NF	NF	I-NP	NN	B-protein	18	NMOD	B-protein
T16	I-Entity	480	481	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T16	I-Entity	481	487	kappaB	kappaB	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	487	488	-	-	B-NP	HYPH	O	22	P	O
O	O	488	497	dependent	dependent	I-NP	JJ	O	22	NMOD	O
O	O	498	513	transcriptional	transcriptional	I-NP	JJ	O	22	NMOD	O
O	O	514	524	activation	activation	I-NP	NN	O	11	PMOD	O
O	O	525	527	of	of	B-PP	IN	O	22	NMOD	O
T17	B-Entity	528	538	downstream	downstream	B-NP	JJ	B-DNA	29	NMOD	B-DNA
T17	I-Entity	539	540	C	C	I-NP	NN	I-DNA	29	NMOD	I-DNA
T17	I-Entity	540	541	(	(	O	(	I-DNA	28	DEP	I-DNA
T17	I-Entity	541	542	H	H	B-NP	NN	I-DNA	28	DEP	I-DNA
T17	I-Entity	542	543	)	)	O	)	I-DNA	25	NMOD	I-DNA
T17	I-Entity	544	549	genes	gene	B-NP	NNS	I-DNA	23	PMOD	I-DNA
O	O	549	550	.	.	O	.	O	2	P	O

O	O	551	554	The	The	B-NP	DT	O	3	NMOD	O
O	O	555	568	physiological	physiological	I-NP	JJ	O	3	NMOD	O
O	O	569	578	relevance	relevance	I-NP	NN	O	7	SUB	O
O	O	579	581	of	of	B-PP	IN	O	3	NMOD	O
O	O	582	586	this	this	B-NP	DT	O	6	NMOD	O
O	O	587	597	phenomenon	phenomenon	I-NP	NN	O	4	PMOD	O
O	O	598	600	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	601	611	emphasized	emphasize	I-VP	VBN	O	7	VC	O
O	O	612	614	by	by	B-PP	IN	O	8	VMOD	O
O	O	615	622	similar	similar	B-NP	JJ	O	14	NMOD	O
T10	B-Protein	623	627	CD30	CD30	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	627	628	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	628	636	mediated	mediate	I-NP	VBN	O	14	NMOD	O
O	O	637	644	effects	effect	I-NP	NNS	O	9	PMOD	O
O	O	645	647	in	in	B-PP	IN	O	14	NMOD	O
O	O	648	653	naive	naive	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	654	655	B	B	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	656	661	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	661	662	.	.	O	.	O	7	P	O

O	O	663	673	Expression	Expression	B-NP	NN	O	7	SUB	O
O	O	674	676	of	of	B-PP	IN	O	1	NMOD	O
T11	B-Protein	677	681	CD30	CD30	B-NP	NN	B-protein	2	PMOD	B-protein
O	O	682	684	by	by	B-PP	IN	O	1	NMOD	O
O	O	685	690	these	these	B-NP	DT	O	6	NMOD	O
O	O	691	696	cells	cell	I-NP	NNS	O	4	PMOD	O
O	O	697	699	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	700	707	induced	induce	I-VP	VBN	O	7	VC	O
O	O	708	710	by	by	B-PP	IN	O	8	VMOD	O
T12	B-Protein	711	716	CD40L	CD40L	B-NP	NN	B-protein	9	PMOD	B-protein
O	O	717	720	but	but	O	CC	O	7	VMOD	O
O	O	721	723	is	be	B-VP	VBZ	O	7	VMOD	O
O	O	724	733	inhibited	inhibit	I-VP	VBN	O	12	VC	O
O	O	734	736	by	by	B-PP	IN	O	13	VMOD	O
O	O	737	738	B	B	B-NP	NN	O	18	NMOD	O
O	O	739	743	cell	cell	I-NP	NN	O	18	NMOD	O
O	O	744	752	receptor	receptor	I-NP	NN	O	18	NMOD	O
O	O	753	765	coengagement	coengagement	I-NP	NN	O	22	NMOD	O
O	O	766	769	and	and	O	CC	O	22	NMOD	O
O	O	769	770	/	/	B-NP	SYM	O	22	NMOD	O
O	O	770	772	or	or	O	CC	O	22	NMOD	O
O	O	773	781	exposure	exposure	B-NP	NN	O	14	PMOD	O
O	O	782	784	to	to	B-PP	TO	O	22	NMOD	O
T13	B-Protein	785	787	IL	IL	B-NP	NN	B-protein	29	NMOD	B-protein
T13	I-Protein	787	788	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
T13	I-Protein	788	789	6	6	I-NP	CD	I-protein	25	NMOD	I-protein
O	O	790	793	and	and	I-NP	CC	O	29	NMOD	O
T18	B-Entity	794	796	IL	IL	I-NP	NN	B-protein	29	NMOD	B-protein
T18	I-Entity	796	797	-	-	I-NP	HYPH	I-protein	23	PMOD	I-protein
T18	I-Entity	797	799	12	12	B-NP	CD	I-protein	29	NMOD	I-protein
O	O	799	800	.	.	O	.	O	7	P	O

O	O	801	804	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	805	809	data	datum	I-NP	NNS	O	3	SUB	O
O	O	810	817	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	818	822	that	that	B-SBAR	IN	O	3	VMOD	O
T14	B-Protein	823	827	CD30	CD30	B-NP	NN	B-protein	7	SUB	B-protein
O	O	828	838	critically	critically	B-ADVP	RB	O	7	VMOD	O
O	O	839	848	regulates	regulate	B-VP	VBZ	O	4	SBAR	O
O	O	849	852	the	the	B-NP	DT	O	12	NMOD	O
T15	B-Protein	853	857	CD40	CD40	I-NP	NN	B-protein	11	AMOD	B-protein
O	O	857	858	-	-	O	HYPH	O	9	P	O
O	O	858	866	mediated	mediate	B-VP	VBN	O	12	NMOD	O
O	O	867	882	differentiation	differentiation	B-NP	NN	O	7	OBJ	O
O	O	883	885	of	of	B-PP	IN	O	12	NMOD	O
O	O	886	889	non	non	B-NP	AFX	O	21	NMOD	O
O	O	889	890	-	-	I-NP	HYPH	B-protein	21	NMOD	B-protein
O	O	890	897	antigen	antigen	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	897	898	-	-	B-VP	HYPH	O	21	P	O
O	O	898	906	selected	select	B-NP	VBN	O	21	NMOD	O
O	O	907	912	human	human	I-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	913	914	B	B	I-NP	NN	I-cell_type	21	NMOD	I-cell_type
O	O	915	920	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	920	921	.	.	O	.	O	3	P	O
